“The clinical formulation of cefiderocol, was tested in the repeat-dose toxicology studies described below. Rats and monkeys were the primary rodent and nonrodent species used in toxicology testing of this drug product.”
✓ VerifiedFDA multi-discipline review, p. 55Source ↗
Why that species
Monkey chosen as non-rodent because dogs vomited and were not expected to tolerate repeat dosing at 1000 mg/kg
“In the response, the Applicant explained that in exploratory single-dose studies in dog, vomiting was observed several times from during dosing to 1 hour after the end of dosing at 1000 mg/kg, reason for which the Applicant considered that dogs would not tolerate repeat-dosing at the 1000 mg/kg dose level.”